Our hospital selection criteria

  • Licensed by China's National Health Commission to administer the specific NMPA-approved CAR-T product required for your case
  • An existing international patient department with English-speaking clinical liaison staff, or a demonstrated track record treating non-Chinese-speaking patients
  • An onsite or closely partnered intensive care unit capable of managing severe cytokine release syndrome or neurological toxicity
  • Willingness to produce a written, itemized quotation and to sign a shared-care agreement with your home physician before treatment begins
  • A track record we can verify independently, not just marketing claims

[Placeholder section — complete before launch]

This page should name your confirmed partner hospital(s), list the specific department and lead clinicians you work with, and include your actual cooperation agreement status. Do not publish named "partner" claims until a signed agreement exists — see the operations document for how to formalize this.

China's CAR-T treatment landscape, for context

International CAR-T treatment in China is a documented, growing field, not a fringe practice. Independent reporting has named several Shanghai institutions already treating patients from overseas, including Jiahui International Cancer Center (part of Jiahui Health), Shanghai International Medical Center, and Shanghai SinoUnited Hospital, which reported treating roughly three dozen international patients from twelve countries since 2023. Separately, Ruijin Hospital's Hainan branch operates within the Boao Lecheng International Medical Tourism Pilot Zone, a special-access framework for selected new biomedical technologies. We reference these as evidence of an established, regulated field — not as a claim that any of them is currently our partner; see the placeholder above for your actual confirmed network.

Medical team structure on every case

MD

Treating physician

A licensed hematologist/oncologist at the treating hospital, responsible for all clinical decisions, diagnosis confirmation and the treatment plan.

CM

Case coordinator

Your single point of contact from first inquiry through follow-up: scheduling, logistics, billing questions and communication with your home physician.

IN

Medical interpreter

Present at every clinical appointment and consent discussion, fluent in medical terminology in both languages, not a general tour guide.

Ask us which hospital would treat your case.

We'll tell you exactly which center and physician we'd propose, and why, as part of your free eligibility review.

Medical disclaimer: CellBridge China is a patient-coordination service and does not provide medical advice, diagnosis or treatment. See our full medical disclaimer.